Menu Search
Equities

EssilorLuxottica SA

EL:PAR

EssilorLuxottica SA

Actions
Health CareMedical Equipment and Services
  • Price (EUR)232.40
  • Today's Change-1.40 / -0.60%
  • Shares traded559.75k
  • 1 Year change+31.31%
  • Beta0.9070
Data delayed at least 15 minutes, as of Nov 21 2024 16:35 GMT.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Consensus recommendation

  • 14-Dec-23
  • 19-Sep-24
  • 17-Oct-24
  • 14-Nov-24
Select bar for recommendation details.
Recommendations14-Nov-24
Buy3
Outperform12
Hold8
Sell0
Strong Sell0

Share price forecast in EUR

The 19 analysts offering 12 month price targets for EssilorLuxottica SA have a median target of 225.00, with a high estimate of 263.00 and a low estimate of 194.00. The median estimate represents a -3.18% decrease from the last price of 232.40.
High13.2%263.00
Med-3.2%225.00
Low-16.5%194.00

Dividends in EUR

In 2023, EssilorLuxottica SA reported a dividend of 3.95 EUR, which represents a 22.29% increase over last year. The 17 analysts covering the company expect dividends of 3.91 EUR for the upcoming fiscal year, a decrease of 0.94%.
Div growth (TTM)22.29%
More ▼

Earnings history & estimates in EUR

EssilorLuxottica SA reported annual 2023 earnings of 6.54 per share on Feb 14, 2024.
Average growth rate+34.93%
More ▼

Revenue history & estimates in EUR

EssilorLuxottica Societe anonyme had revenues for the full year 2023 of 25.40bn. This was 3.68% above the prior year's results.
Average growth rate+11.90%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.